Use of cyclophosphamide regimen found effective in hard-to-treat MG

Phase 1 trial of NKX019 cell therapy in gMG patients cleared to open

An investigator-initiated clinical trial will assess the safety and efficacy of NKX019, Nkarta’s investigational natural killer (NK) cell therapy for autoimmune diseases, in people with myasthenia gravis (MG). The open-label Phase 1 trial will be led by researchers at the University of California, Irvine, and the University…

Navigating the emotional ups and downs of life with MG

There’s no denying it: Living with myasthenia gravis (MG) can make a person feel insane. One minute I’m celebrating a new physical milestone achieved, and the next I’m lamenting and grieving how much I lost when I got sick. It’s these constant emotional ups and downs that make…

Coping with myasthenia gravis meant staying silent

“Silence is a true friend who never betrays,” Confucius once said. There is so much modern science doesn’t know about myasthenia gravis (MG). It must be taxing and frustrating for people with MG to explain the disease and its symptoms to family, friends, and others who may have…

Disease crises linked to more hospital time for MG patients

People with myasthenia gravis (MG) who experience exacerbations tend to require longer and more frequent hospital stays, according to a recent study. Findings from the study, which analyzed data from a U.S. Veterans Affairs (VA) healthcare database, also suggest the risk of exacerbations is higher in people with MG…